Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury

Stem Cells International

Volumn 2015, Issue , 2015, Pages

  Zhao, Yuanyuan ^a   Sun, Xiaoxian ^a   Cao, Wenming ^a   Ma, Jie ^a   Sun, Li ^a   Qian, Hui ^a   Zhu, Wei ^a   Xu, Wenrong ^a  

^a JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; CISPLATIN; DYE; KI 67 ANTIGEN; NANOPARTICLE; TRICHROME; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL LINE; CARDIAC SYSTOLIC FUNCTION; CELL COUNT; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CELL REGENERATION; CELL TRACKING; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; EA.HY926 CELL LINE; ECHOCARDIOGRAPHY; EXOSOME; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIGATION; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; STAINING; SYSTOLE; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; UMBILICAL CORD MESENCHYMAL STEM CELL TRANSPLANTATION;

RATTUS;

EID: 84935874875     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2015/761643     Document Type: Article

References (38)

1. B. Hynes, A. H. S. Kumar, J. OSullivan et al., "Potent endothelial progenitor cell-conditioned media-related anti-apoptotic, cardiotrophic, and pro-angiogenic effects post-myocardial infarction are mediated by insulin-like growth factor-1," European Heart Journal, vol. 34, no. 10, pp. 782-789, 2013.
2. C. Valina, K. Pinkernell, Y.-H. Song et al., "Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction," European Heart Journal, vol. 28, no. 21, pp. 2667-2677, 2007.
3. F. van den Akker, J. C. Deddens, P. A. Doevendans, and J. P. G. Sluijter, "Cardiac stem cell therapy to modulate inflammation uponmyocardial infarction," Biochimica et Biophysica Acta, vol. 1830, no. 2, pp. 2449-2458, 2013.
4. M. Rota, M. E. Padin-Iruegas, Y. Misao et al., "Local activation or implantation of cardiac progenitor cells rescues scarred infarctedmyocardium improving cardiac function," Circulation Research, vol. 103, no. 1, pp. 107-116, 2008.
5. K. H. Schuleri, G. S. Feigenbaum, M. Centola et al., "Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy," European Heart Journal, vol. 30, no. 22, pp. 2722-2732, 2009.
6. J. M. Hare, J. H. Traverse, T. D. Henry et al., "A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction," Journal of the American College of Cardiology, vol. 54, no. 24, pp. 2277-2286, 2009.
7. G. Vassalli and T. Moccetti, "Cardiac repair with allogeneic mesenchymal stem cells after myocardial infarction," Swiss MedicalWeekly, vol. 141, Article ID w13209, 2011.
8. J. G. Shake, P. J. Gruber, W. A. Baumgartner et al., "Mesenchymal stemcell implantation in a swinemyocardial infarct model: engraftment and functional effects," The Annals of Thoracic Surgery, vol. 73, no. 6, pp. 1919-1926, 2002.
9. R. R. Makkar, M. J. Price, M. Lill et al., "Intramyocardial injection of allogenic bone marrow-derived mesenchymal stem cells without immunosuppression preserves cardiac function in a porcine model ofmyocardial infarction," Journal of Cardiovascular Pharmacology andTherapeutics, vol. 10, no. 4, pp. 225-233, 2005.
10. H. Kawada, J. Fujita, K. Kinjo et al., "Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes aftermyocardial infarction," Blood, vol. 104, no. 12, pp. 3581-3587, 2004.
11. N. Nagaya, K. Kangawa, T. Itoh et al., "Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy," Circulation, vol. 112, no. 8, pp. 1128-1135, 2005.
12. R. Hass, C. Kasper, S. Bohm, and R. Jacobs, "Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC," Cell Communication and Signaling, vol. 9, article 12, 2011.
13. R. A. Pelekanos, J. Li, M. Gongora et al., "Comprehensive transcriptome and immunophenotype analysis of renal and cardiacMSC-like populations supports strong congruence with bone marrow MSC despite maintenance of distinct identities," Stem Cell Research, vol. 8, no. 1, pp. 58-73, 2012.
14. J. J. H. Chong, V. Chandrakanthan, M. Xaymardan et al., "Adult cardiac-residentMSC-like stemcellswith a proepicardial origin," Cell Stem Cell, vol. 9, no. 6, pp. 527-540, 2011.
15. D. Baksh, R. Yao, and R. S. Tuan, "Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow," Stem Cells, vol. 25, no. 6, pp. 1384-1392, 2007.
16. M. L. Weiss, C. Anderson, S. Medicetty et al., "Immune properties of human umbilical cord Whartons jelly-derived cells," Stem Cells, vol. 26, no. 11, pp. 2865-2874, 2008.
17. Y. Chen, H. Qian, W. Zhuet al., "Hepatocytegrowthfactormodification promotes the amelioration effects of human umbilical cord mesenchymal stem cells on rat acute kidney injury," Stem Cells and Development, vol. 20, no. 1, pp. 103-113, 2011.
18. H. Cao, H. Qian, W. Xu et al., "Mesenchymal stem cells derived from human umbilical cord ameliorate ischemia/reperfusioninduced acute renal failure in rats," Biotechnology Letters, vol. 32, no. 5, pp. 725-732, 2010.
19. Y. Yan, W. Xu, H. Qian et al., "Mesenchymal stem cells from human umbilical cords ameliorate mouse hepatic injury in vivo," Liver International, vol. 29, no. 3, pp. 356-365, 2009.
20. H. Qian, H. Yang, W. Xu et al., "Bone marrow mesenchymal stem cells ameliorate rat acute renal failure by differentiation into renal tubular epithelial-like cells," International Journal of Molecular Medicine, vol. 22, no. 3, pp. 325-332, 2008.
21. M. Rota, J. Kajstura, T. Hosoda et al., "Bone marrow cells adopt the cardiomyogenic fate in vivo," Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 45, pp. 17783-17788, 2007.
22. M. Xu, M. Wani, Y.-S. Dai et al., "Differentiation of bonemarrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes," Circulation, vol. 110, no. 17, pp. 2658-2665, 2004.
23. Y. Miyahara, N. Nagaya, M. Kataoka et al., "Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction," Nature Medicine, vol. 12, no. 4, pp. 459-465, 2006.
24. L. Wang, J. Deng, W. Tian et al., "Adipose-derived stem cells are an effective cell candidate for treatment of heart failure: an MR imaging study of rat hearts," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 297, no. 3, pp. H1020-H1031, 2009.
25. M. Gnecchi, Z. Zhang, A. Ni, and V. J. Dzau, "Paracrine mechanisms in adult stem cell signaling and therapy," Circulation Research, vol. 103, no. 11, pp. 1204-1219, 2008.
26. D. Kuraitis, M. Ruel, and E. J. Suuronen, "Mesenchymal stem cells for cardiovascular regeneration," Cardiovascular Drugs and Therapy, vol. 25, no. 4, pp. 349-362, 2011.
27. L. Timmers, S. K. Lim, F. Arslan et al., "Reduction ofmyocardial infarct size by human mesenchymal stem cell conditioned medium," Stem Cell Research, vol. 1, no. 2, pp. 129-137, 2008.
28. R. C. Lai, F. Arslan, M. M. Lee et al., "Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury," Stem Cell Research, vol. 4, no. 3, pp. 214-222, 2010.
29. R. C. Lai, T. S. Chen, and S. K. Lim, "Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease," Regenerative Medicine, vol. 6, no. 4, pp. 481-492, 2011.
30. T. Li, Y. Yan, B. Wang et al., "Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis," Stem Cells and Development, vol. 22, no. 6, pp. 845-854, 2013.
31. Y. Zhou, H. Xu, W. Xu et al., "Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro," Stem Cell Research and Therapy, vol. 4, no. 2, article 34, 2013.
32. B. Zhang, M. Wang, A. Gong et al., "HucMSC-exosome mediated-wnt4 signaling is required for cutaneous wound healing," Stem Cells, 2015.
33. C. Qiao, W. Xu, W. Zhu et al., "Human mesenchymal stem cells isolated fromthe umbilical cord," Cell Biology International, vol. 32, no. 1, pp. 8-15, 2008.
34. J.-L. Qu, X.-J. Qu, M.-F. Zhao et al., "Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation," Digestive and Liver Disease, vol. 41, no. 12, pp. 875-880, 2009.
35. B. Yu, H. W. Kim, M. Gong et al., "Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection," International Journal of Cardiology, vol. 182, pp. 349-360, 2015.
36. S. Bian, L. Zhang, L. Duan, X. Wang, Y. Min, and H. Yu, "Extracellular vesicles derived from human bone marrow mesenchymal stem cells promote angiogenesis in a rat myocardial infarction model," Journal of Molecular Medicine, vol. 92, no. 4, pp. 387-397, 2014.
37. R. C. Lai, S. S. Tan, B. J. Teh et al., "Proteolytic potential of the msc exosome proteome: implications for an exosome-mediated delivery of therapeutic proteasome," International Journal of Proteomics, vol. 2012, Article ID 971907, 14 pages, 2012.
38. F. Arslan, R. C. Lai, M. B. Smeets et al., "Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury," Stem Cell Research, vol. 10, no. 3, pp. 301-312, 2013.